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n	 INTRODUCTION
Thromboangiitis obliterans (TAO), also known as Buerger’s disease, is a seg-
mental vasculitis of small and medium-
sized arteries causing obstruction of blood 
vessels (1). The average age of onset is 
around 40-45 years, and males are more fre-
quently affected (2). Although its etiology 
is unknown, tobacco consumption plays a 
critical role in its pathogenesis (3-5). Clini-
cally TAO is characterized by coldness and 
rest pain in the distal extremities, due to 
ischemic manifestations which might also 
lead to Raynaud’s phenomenon, acrocyano-
sis, and necrosis of finger tips (6). To date, 
the cornerstone of management is smoking 
cessation, whereas other treatments aimed 
at improving the blood flow and dilating 
the blood vessels are less effective (7). We 
herein describe the case of a female patient 
presenting with an uncommon coexistence 
of axial spondyloarthritis (SpA) and TAO.
n	 CASE REPORT
In March 2014, a 45-year-old female 
heavy smoker was hospitalized for clini-
cal assessment of ischemia of feet and the 
fourth finger of the left hand. Her medical 
history started in 2008 with inflammatory 
polyarthralgia in the wrists, feet, elbows, 
and knees accompanied by inflamma-
tory low-back pain. HLA-B35 was found 
and tenosynovitis in tendons of her hands 
was detected by ultrasonography. Finally, 
according to the Assessment of Spondy-
loarthritis International Society (ASAS) 
classification criteria, an axial SpA was 
diagnosed on the basis of the outcome of 
spine magnetic resonance imaging, which 
revealed a right sacroiliitis (unavailable 
images). Over the following 6 years she 
was treated with prednisone, salazopyrin 
and etanercept, reaching a clinical amelio-
ration of joint symptoms. In August 2013 
the patient presented Raynaud’s phenom-
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A peculiar coexistence of axial spondyloarthritis and ischemia of the feet and the fourth finger of the left hand 
in a young woman, who was a heavy smoker, is discussed in this report. This picture was considered within 
the context of thromboangiitis obliterans. Positivity of anti-nuclear antibodies and mild elevation of inflam-
matory parameters were noted. Computed tomography angiograms of upper and lower limbs showed luminal 
narrowing and occlusion of the left humeral, left anterior/posterior tibial and right anterior tibial arteries. Daily 
iloprost perfusions were started, and smoking cessation was strongly recommended. Coldness and rest pain in 
the distal extremities improved within a few weeks. The possibility that spondyloarthritis might precede the 
clinical picture of thromboangiitis obliterans should be considered in heavy smokers.
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enon, involving her left hand and feet, and 
rest pain of the fourth fingertip combined 
with ischemic ulceration. When admitted 
to our Unit, laboratory investigations were 
as follows: C-reactive protein 10 mg/L 
[normal value (n.v.) <3] and erythrocyte 
sedimentation rate 31 mm/h (n.v. <25). Au-
toimmunity tests revealed the positivity of 
anti-nuclear antibodies (titre of 1:640 with 
a fine speckled nuclear pattern), whereas 
anti-extractable nuclear antigens antibod-
ies, anti-dsDNA antibodies, anti-citrul-
linated protein antibodies, rheumatoid 
factor, and anti-neutrophil cytoplasmic 
antibodies were all negative. Screening 
for hypercoagulopathy was also negative. 
Echocardiography and nailfold videocap-
illaroscopy gave normal results. However, 
an abnormal distal pulse was recognized 
at the left upper limb. As the patient com-
plained low-back pain, X-ray of the pelvis 
was carried out, revealing the presence of 
subchondral sclerosis on the iliac side of 
the right sacroiliac joint. A computed to-
mography (CT)-angiography of upper and 
lower limbs was also performed, disclos-
ing luminal narrowing and occlusion of 
the left humeral artery, left anterior and 
posterior tibial arteries and the right an-
terior tibial artery (Fig. 1). Moreover, CT 
scans showed erosions on the iliac side of 
the left sacroiliac joint (Fig. 2). On the ba-
sis of the narrowing and occlusion of ar-
teries highlighted by CT-angiography, in 
agreement with the diagnostic criteria of 
Olin (8), the patient was diagnosed with 
TAO. Since the patient continued to com-
plain inflammatory back pain, suggesting 
a loss of efficacy of etanercept, and con-
sidering that several urinary infections had 
occurred during the anti-tumor necrosis 
factor (TNF) treatment, etanercept was 
discontinued, while iloprost daily perfu-
sions were started. Smoking cessation was 
strongly recommended. 
Within a few weeks the patient reported a 
subjective improvement of coldness and 
rest pain: although the use of corticoste-
roids and sulfasalazine for the treatment 
of axial SpA is not supported by any evi-
dence, the patient is currently treated with 
low-dose prednisone and salazopyrin, 
though a new biologic drug treatment has 
been proposed.
Figure 1 - Computed tomography angiograms showing luminal narrowing and occlusion of 
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n	 DISCUSSION
TAO is a non-atherosclerotic vasculitis 
with a self-limiting course, characterized 
by inflammation of medium and small-
sized arteries in the arms and legs, particu-
larly radial and tibial arteries (9). Although 
its pathogenesis is not well understood, to-
bacco seems pivotal in the onset of this dis-
ease (2). In this regard, Papa et al. showed 
a cell-mediated immune response against 
human artery type-specific collagen in the 
presence of a peculiar genetic susceptibility 
(4). Women are less frequently involved by 
TAO, nevertheless a higher consumption of 
tobacco has been recently observed in the 
female sex (10). Keeping into account the 
age of onset, smoking habit, the type, size 
and location of vasculitis, we ruled out the 
possibility of other diagnostic explanations 
in our patient, such as Takayasu arteritis 
(11, 12). In agreement with the study of 
Sasaki et al., carried out to clarify the dis-
tribution of vasculitides in TAO, our patient 
presented vascular involvement of anterior 
and posterior tibial arteries in the lower 
extremities (9). Non erosive mono/oligo-
arthritis affecting large joints can occur up 
to 10 years before the first occlusive sign of 
TAO, often leading to a misinterpretation of 
the clinical phenotype (13). For these rea-
sons, patients presenting with polyarthritis 
may be diagnosed with undifferentiated 
spondyloarthropathies, as occurred in our 
patient, showing signs suggestive of SpA 
six years before TAO (14). As suggested by 
Ernst et al., the possibility for a common 
inflammatory process to lead to both axial 
SpA and TAO could be the sole plausible 
explanation in our patient (15). Indeed the 
coexistence of SpA and leukocytoclastic 
vasculitis was reported previously (16, 17), 
corroborating the concept that vascular 
manifestations may be associated with in-
flammatory joint involvement. Regarding 
our patient, smoking might have played a 
pathogenic key-role in the onset of these 
two diseases. Smoking is indeed capable 
of activating inflammatory cells, such 
as dendritic cells and Th17 lymphocytes 
through the NF-kB pathway, in SpA. (18). 
Likewise, nicotine may induce the expres-
sion of unknown antigens in the vascular 
endothelium, triggering immune-mediated 
responses that lead to the vascular damage 
involved in TAO (19).
n	 CONCLUSIONS
The main feature of our case is the unre-
ported association between axial SpA and 
TAO: although it is unclear if sacroiliitis 
reflects a mere association with TAO or 
if they represent two coinciding immune-
mediated disorders, the possibility that sac-
roiliitis might occasionally precede TAO 
should be contemplated in heavy smokers. 
Conflict of interests: the authors declare 
no potential conflict of interest.
Contributions: GL and FI contributed 
equally to this manuscript.
n	 REFERENCES
1. Dargon PT, Landry GJ. Buerger’s disease. 
Ann Vasc Surg. 2012; 26: 871-80.
2. Arkkila PE. Thromboangiitis obliterans 
(Buerger’s disease). Orphanet J Rare Dis. 
2006; 1: 14.
3. Adar R, Papa MZ, Halpern Z, Mozes M, 
Shoshan S, Sofer B, et al. Cellular sensitivity 
to collagen in thromboangiitis obliterans. N 
Engl J Med. 1983; 308: 1113-6.
Figure 2 - Computed tomography scans dis-
playing erosions on the iliac side of the left 
sacroiliac joint combined with a slightly poor 











case report G. Lopalco, F. Iannone, D. Rigante et al.
4. Papa M, Bass A, Adar R, Halperin Z, Schnei-
derman J, Becker CG, et al. Autoimmune 
mechanisms in thromboangiitis obliterans 
(Buerger’s disease): the role of tobacco anti-
gen and the major histocompatibility complex. 
Surgery. 1992; 111: 527-31.
5. Matsushita M, Shionoya S, Matsumoto T. Uri-
nary cotinine measurement in patients with 
Buerger’s disease - Effects of active and pas-
sive smoking on the disease process. J Vasc 
Surg. 1991; 14: 53-8.
6. Vijayakumar A, Tiwari R, Kumar Prabhus-
wamy V. Thromboangiitis obliterans (Buerg-
er’s disease) - Current practices. Int J Inflam. 
2013; 2013: 156905. 
7. Puéchal X, Fiessinger JN. Thromboangiitis 
obliterans or Buerger’s disease: challenges for 
the rheumatologist. Rheumatology (Oxford). 
2007; 46: 192-9.
8. Olin JW. Thromboangiitis obliterans (Buerg-
er’s disease). N Engl J Med. 2000; 343: 864-9.
9. Sasaki S, Sakuma M, Kunihara T, Yasuda K. 
Distribution of arterial involvement in throm-
boangiitis obliterans (Buerger’s disease): re-
sults of a study conducted by the Intractable 
Vasculitis Syndromes Research Group in Ja-
pan. Surg Today. 2000; 30: 600-5.
10. Mills JL, Taylor LM Jr, Porter JM. Buerger’s 
disease in the modern era. Am J Surg. 1987; 
154: 123-9.
11. Ishikawa K. Diagnostic approach and pro-
posed criteria for the clinical diagnosis of 
Takayasu’s arteriopathy. J Am Coll Cardiol. 
1988; 12: 964-72.
12. Arend WP, Michel BA, Bloch DA, Hunder 
GG, Calabrese LH, Edworthy SM, et al. The 
American College of Rheumatology 1990 cri-
teria for the classification of Takayasu arteri-
tis. Arthritis Rheum. 1990; 33: 1129-34.
13. Lambotte O, Chazerain P, Vinciguerra C, 
Meyer O, Ziza JM. Thromboangiitis obliter-
ans with inaugural rheumatic manifestations. 
A report of three cases. Rev Rhum Engl Ed. 
1997; 64: 334-8.
14. Puéchal X, Fiessinger JN, Kahan A, Menkès 
CJ. Rheumatic manifestations in patients with 
thromboangiitis obliterans (Buerger’s dis-
ease). J Rheumatol. 1999; 26: 1764-8.
15. Ernst D, Baerlecken N, Schmidt R, Witte T. 
Large vessel vasculitis and spondyloarthritis: 
coincidence or associated diseases? Scand J 
Rheumatol. 2014; 43: 246-8.
16. Kobak S, Yilmaz H, Karaarslan A, Yalcin M. 
Leukocytoclastic vasculitis in a patient with 
ankylosing spondylitis. Case Rep Rheumatol. 
2014; 2014: 653837.
17. Hsu CM, Kuo SY, Chu SJ, Shih TY, Chen A, 
Huang GS, et al. Coexisting IgA nephropathy 
and leukocytoclastic cutaneous vasculitis as-
sociated with ankylosing spondylitis: a case 
report. Zhonghua Yi Xue Za Zhi (Taipei). 
1995; 55: 83-8.
18. Wendling D. IL-23 and IL-17 in ankylosing 
spondylitis. Rheumatol Int. 2010; 30: 1547.
19. Little MA, Savage CO. The role of the endo-
thelium in systemic small vessel vasculitis. 
Clin Exp Rheumatol. 2008; 26: S135-40.
No
n-c
om
me
rci
al 
us
e o
nly
